Talimogene Laherparepvec Enhances the Efficacy of PD-1 Blockade [Research Watch]

Talimogene laherparepvec plus pembrolizumab achieved response in 62% of patients with melanoma.

from Cancer via ola Kala on Inoreader http://ift.tt/2ywjlPY
via IFTTT